Caribbean Genomics Healthcare Transformation Q1 2024 Investor Deck

An investor presentation outlining precision medicine solutions tailored for Caribbean and underrepresented populations. The deck addresses the gap in drug development for the 85% of the global population not served by European-designed medications, leveraging genomics and precision medicine to enable personalized treatments and accelerate pharmaceutical R&D efficiency.